Drugs / Xihuang Pill
last change Jun 2025 re-read 2 minutes ago

Xihuang Pill

Developed for
breast cancer
Investigated by
Zhejiang Provincial People's Hospital

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT05914753 Jul 2023 → Jun 2024 breast cancer Zhejiang Provincial People's Hospital Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Xihuang Pill ClinicalTrials.gov intervention name — accepted as the source's own label NCT05914753
Route Oral “Xihuang Pill:3g po bid,4 cycles” NCT05914753